Tags

Type your tag names separated by a space and hit enter

Nonalcoholic fatty liver disease: defining a common problem.
Eur Rev Med Pharmacol Sci. 2005 Sep-Oct; 9(5):253-9.ER

Abstract

Non Alcoholic Fatty Liver Disease (NAFLD), with prevalence of 10-51% in general population involving all ages, is the major cause of elevation of ALT and a common finding by ultrasound screening and may range from simple steatosis, to Non Alcoholic Steatohepatitis (NASH) and its clinical consequences as cirrhosis and hepatocellular carcinoma. In this review will be analyse factors influencing the onset of the disease. NAFLD, primarly associated with insulin resistance, is in fact considered the hepatic manifestation of the metabolic syndrome: a cluster of disorder that includes obesity, diabetes mellitus, dyslipidaemia, arteriosclerosis and hypertension. The increased incidence and prevalence of obesity and diabetes may explain growing interest in NAFLD. Racial, ethnic, enviromental and behaviour models are also reviewed.

Authors+Show Affiliations

Department of Internal Medicine, Catholic University of Sacred Heart, Rome, Italy.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

16231586

Citation

Gasbarrini, G, et al. "Nonalcoholic Fatty Liver Disease: Defining a Common Problem." European Review for Medical and Pharmacological Sciences, vol. 9, no. 5, 2005, pp. 253-9.
Gasbarrini G, Vero V, Miele L, et al. Nonalcoholic fatty liver disease: defining a common problem. Eur Rev Med Pharmacol Sci. 2005;9(5):253-9.
Gasbarrini, G., Vero, V., Miele, L., Forgione, A., Hernandez, A. P., Greco, A. V., Gasbarrini, A., & Grieco, A. (2005). Nonalcoholic fatty liver disease: defining a common problem. European Review for Medical and Pharmacological Sciences, 9(5), 253-9.
Gasbarrini G, et al. Nonalcoholic Fatty Liver Disease: Defining a Common Problem. Eur Rev Med Pharmacol Sci. 2005 Sep-Oct;9(5):253-9. PubMed PMID: 16231586.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Nonalcoholic fatty liver disease: defining a common problem. AU - Gasbarrini,G, AU - Vero,V, AU - Miele,L, AU - Forgione,A, AU - Hernandez,A P, AU - Greco,A V, AU - Gasbarrini,A, AU - Grieco,A, PY - 2005/10/20/pubmed PY - 2006/4/19/medline PY - 2005/10/20/entrez SP - 253 EP - 9 JF - European review for medical and pharmacological sciences JO - Eur Rev Med Pharmacol Sci VL - 9 IS - 5 N2 - Non Alcoholic Fatty Liver Disease (NAFLD), with prevalence of 10-51% in general population involving all ages, is the major cause of elevation of ALT and a common finding by ultrasound screening and may range from simple steatosis, to Non Alcoholic Steatohepatitis (NASH) and its clinical consequences as cirrhosis and hepatocellular carcinoma. In this review will be analyse factors influencing the onset of the disease. NAFLD, primarly associated with insulin resistance, is in fact considered the hepatic manifestation of the metabolic syndrome: a cluster of disorder that includes obesity, diabetes mellitus, dyslipidaemia, arteriosclerosis and hypertension. The increased incidence and prevalence of obesity and diabetes may explain growing interest in NAFLD. Racial, ethnic, enviromental and behaviour models are also reviewed. SN - 1128-3602 UR - https://www.unboundmedicine.com/medline/citation/16231586/Nonalcoholic_fatty_liver_disease:_defining_a_common_problem_ L2 - http://www.diseaseinfosearch.org/result/4280 DB - PRIME DP - Unbound Medicine ER -